A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Clinical trial NCT01280552 · COMPLETED

Trial details

NCT number: NCT01280552
Sponsor: Precision Life Sciences Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2011-01-01
Primary completion: 2013-12-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.